FDA Logo U.S. Food and Drug AdministrationCenter for Food Safety and Applied Nutrition
U.S. Department of Health and Human Services
horizontal rule

CFSAN/Office of Food Additive Safety
December 2008

horizontal rule

GRAS Notices Received in 2007

Information about the Notifier, the Intended Use, and the Basis for the GRAS Determination

A substance that will be added to food is subject to premarket approval by FDA unless its use is generally recognized as safe (GRAS) by qualified experts.(1) On April 17, 1997, FDA issued a proposed rule (the GRAS proposal; 62 FR 18938) that would establish a notification procedure whereby any person may notify FDA of a determination by that person that a particular use of a substance is GRAS. Although the proposed notification procedure is not yet final, FDA has already received several notices. As described in the GRAS proposal, the agency is evaluating whether each submitted notice provides a sufficient basis for a GRAS determination and whether information in the notice or otherwise available to FDA raises issues that lead the agency to question whether use of the substance is GRAS. Following this evaluation, FDA replies to the notifier by letter.

In general, FDA's response has been in one of three categories:

  1. The agency does not question the basis for the notifier's GRAS determination;
  2. The agency concludes that the notice does not provide a sufficient basis for a GRAS determination (e.g., because the notice does not include appropriate data and information or because the available data and information raise questions about the safety of the notified substance); or
  3. The response letter states that the agency has, at the notifier's request, ceased to evaluate the GRAS notice.

In the GRAS proposal, FDA announced its intention to maintain an inventory of GRAS notices and the agency's response to those notices. The main page of the Inventory of GRAS Notices lists all notices that FDA has received, describes FDA's response as one of the three general categories described above, and provides a hyperlink to the actual response letter. The table below, which is a separate part of the Inventory of GRAS Notices, lists the notices that FDA received in the year 2007. Importantly, the table below lists all GRAS notices received in the year 2007, regardless of whether the notice is pending at FDA or has come to closure.

The table below:

This table is current as of December 17, 2008, and therefore does not show any new notices filed by FDA, or response letters issued by FDA, after that date. This table will be updated approximately monthly.

List of GRAS Notices Received in 2007
GRN No. Notifier Substance Intended Use GRP # Basis Date of filing Closure
238 Genencor, a Danisco Division Lipase enzyme preparation derived from Hansenula polymorpha expressing a gene encoding a lipase from Fusarium heterosporum As an enzyme to modify lipids in dough for bakery and noodle applications, in egg yolks for bakery applications and mayonnaise production, and in the refining process of soy bean oil   Scientific procedures Dec. 27, 2007 July 28, 2008
237 Cognis Corporation Alkyl polyglycosides Use in the cleaning of foods, including fruits, vegetables, meat, and poultry products   Scientific procedures Dec. 19, 2007 Oct. 14, 2008
236 Friesland Foods Domo Galacto-oligosaccharides Ingredient in term infant formula at a level of 5 grams (g) per liter, and in bars, yogurt, frozen dairy desserts, fruit drinks and energy drinks, fitness water and thirst quenchers, fruit pie filling, fruit preparation, jelly and jam, baby juice, baby yogurt drink, baby dessert, baby snack, milk, milk drinks, syrup flavorings for milk, meal replacement drinks, meal replacement drinks for children, and milk substitutes at levels ranging from 1 to 7.5 g per serving   Scientific procedures Nov. 7, 2007 July 28, 2008
235 Ventria BioScience Lactoferrin (human) purified from rice Ingredient in oral rehydration solutions at levels not to exceed 1.0 milligrams per milliliter   Scientific procedures Oct. 19, 2007  
234 Proliant Health Ingredients Inc. Bovine globulin Ingredient in dairy foods, juices, snack foods, beverages and meal replacements at maximum levels of 5 per cent of the finished product   Scientific procedures Sept. 17, 2007 Feb. 14, 2008 
233 Mead Johnson & Company Galactooligosaccharides and polydextrose Ingredients in milk-based term infant formulas, at levels not to exceed 5.0 grams per liter (g/l) and 2.5 g/l, respectively   Scientific procedures Sept. 5, 2007  
232 Lipid Nutrition B.V.
AND
Cognis GmbH
Conjugated linoleic acid isomers Ingredient in certain specified foods within the general categories of soy milk, meal replacement beverages and bars, milk products and fruit juices at levels not to exceed 1.5 grams per serving   Scientific procedures Aug. 13, 2007  July 11, 2008
231 Mead Johnson & Company Lactobacillus casei subsp. rhamnosus strain GG Ingredient in term infant formula, at levels not to exceed 108 colony forming units per gram of powdered formula   Scientific procedures Aug. 9, 2007 May 29, 2008 
230 Genencor, A Danisco Division Chymosin enzyme preparation from Trichoderma reesei expressing the bovine prochymosin B gene As an enzyme for milk coagulation during cheese making   Scientific procedures July 27, 2007 Feb. 19, 2008 
229 Bergstrom Nutrition Methylsulfonylmethane Ingredient in meal supplement and meal replacement foods, fruit smoothie-type drinks and fruit-flavored thirst quencher-type beverages at levels up to 4000 milligrams per kilogram (mg/kg); and in food bars such as granola bars and energy-type bars at levels up to 30,000 mg/kg   Scientific procedures July 25, 2007 Feb. 18, 2008 
228 Bemis Company, Inc Sodium nitrite Addition to the surface of raw beef via migration from packaging film to maintain the characteristic color of raw beef at a maximum level of 113 miligrams per square meter   Scientific procedures July 10, 2007  
227 The Procter & Gamble Company Olestra Use as a total replacement for fats and oils in pre-packaged, ready-to-eat cookies   Scientific procedures June 27, 2007 Oct. 9, 2008
226 Enzymotec Ltd. Lecithin derived from krill Ingredient in breakfast bars at a level of 3.8 per cent, dairy product analogs (soy products) and milk-based beverages at a level of 0.6 per cent, fat spreads at a level of 10 per cent, yogurt at a level of 0.7 per cent, and soft candy at a level of 3.3 per cent   Scientific procedures May 31, 2007  Jan. 3, 2008
225 Kao Corporation Catechins from green tea extract Ingredient in beverages, including bottled teas, sport drinks, carbonated soft drinks and juice, at levels according to current good manufacturing practices   Scientific procedures May 24, 2007  Nov. 26, 2007
224 ATLA Holdings, LLC trans-Resveratrol Ingredient in bottled water products at levels up to 10 milligrams per liter   Scientific procedures May 22, 2007  Aug. 1, 2007
223 Enzymotec Ltd. Phosphatidylserine Ingredient in milk, flavored milk, milk drinks (excluding milk, fluid), milk imitation (soy milk), milk-based meal replacement , yogurt, breakfast bars, and fruit flavored drink at levels of 100 milligrams (mg) phosphatidylserine per serving and in breakfast cereals and milk, fluid at 50 mg/serving   Scientific procedures May 22, 2007 Dec. 20, 2007 
222 Laboratorios Miret S.A. (LAMIRSA) Citric acid esters of mono- and diglycerides As an emulsifier in combination with lauramide ethyl ester in food in general, including meat and poultry   Scientific procedures May 1, 2007  Dec. 20, 2007
221 Kemin Health, L.C. Suspended lutein Ingredient in term infant formula at a maximum level of 250 micrograms/liter   Scientific procedures Apr. 11, 2007  Oct. 23, 2007 
220 San-Ei Gen F.F.I., Inc. alpha-Glycosyl isoquercitrin As an antioxidant in multiple food categories at 150 milligrams per kilogram (mg/kg) and in chewing gum at 1500 mg/kg   Scientific procedures Apr. 4, 2007  Nov. 19, 2007
219 Palsgaard A/S Ammonium phosphatide As an emulsifier in chocolate and vegetable fat coatings at levels up to 0.7%   Scientific procedures Jan. 3, 2007 June 29, 2007 



(1)In addition, a substance that is used in accordance with a sanction granted prior to September 6, 1958 is not subject to premarket approval.

 

horizontal rule
horizontal rule